|
Volumn , Issue , 2013, Pages 118-125
|
Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COOPERATION;
DEVICE APPROVAL;
DRUG APPROVAL;
DRUG DEVELOPMENT;
ECONOMICS;
EUROPE;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
MEDICAL RESEARCH;
MOLECULARLY TARGETED THERAPY;
NEOPLASMS;
PERSONALIZED MEDICINE;
PROCEDURES;
BIOMEDICAL RESEARCH;
COOPERATIVE BEHAVIOR;
DEVICE APPROVAL;
DRUG APPROVAL;
DRUG DISCOVERY;
EUROPE;
HUMANS;
INDIVIDUALIZED MEDICINE;
MOLECULAR TARGETED THERAPY;
NEOPLASMS;
|
EID: 84885476862
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.118 Document Type: Review |
Times cited : (33)
|
References (0)
|